| Mr James Hodo Walburn, MD | |
|
1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406-2283 | |
| (205) 758-9041 | |
| (205) 345-8328 |
| Full Name | Mr James Hodo Walburn |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 1300 Mcfarland Blvd Ne, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558398412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 00003830 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Hodo Walburn, MD 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406-2283 Ph: (205) 758-9041 | Mr James Hodo Walburn, MD 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406-2283 Ph: (205) 758-9041 |
News Archive
Press Ganey today announced the launch of its Child Hospital Consumer Assessment of Healthcare Providers and Systems Hospital Survey (Child HCAHPS) survey solution, complementing the company's Inpatient Pediatric solution and expanding its portfolio of industry-leading CAHPS solutions.
Vaping or using e-cigarettes has gained immense population over the past few years. It's widely regarded as a healthier alternative to cigarette smoking. Now, health officials warn against vaping as the Centers for Disease Control and Prevention (CDC) says that a cluster of lung diseases associated with e-cigarette use was reported in 14 states.
Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors.
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
› Verified 4 days ago
Mr. James Edgar Shotts Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. Lee Headley Loftin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. Gary Mathers Lake Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. David Bruce Rosenstiel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Dr. Salem K David Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1224 Mcfarland Blvd Ne, Suite A, Tuscaloosa, AL 35406 Phone: 205-759-9930 Fax: 205-759-9931 | |
Dr. Craig Michael Benoit, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 302 Merchants Walk, Suite 100, Tuscaloosa, AL 35406 Phone: 205-523-9300 Fax: 205-523-9301 |